jaundice, excess accumulation of bile pigments in the bloodstream and bodily tissues that causes a yellow to orange and sometimes even greenish discoloration of the skin, the whites of the eyes, and the mucous membranes. Jaundice is best seen in natural daylight and may not be apparent under artificial lighting. The degree of coloration depends on the concentration of bile pigment (bilirubin) in the blood, its rate of tissue diffusion, and the absorption and binding of bilirubin by the tissue. Bilirubin enters the tissue fluids and is absorbed more readily at sites of inflammation and edema (abnormal accumulation of fluids in the tissues).
The most common mechanisms causing jaundice are an overproduction of bile by the liver, so that more is produced than can be readily excreted; congenital defects, which may impair the removal of bile pigments or cause overproduction; inability of liver cells to remove bile pigments from the blood because of liver disease; leakage of bilirubin removed by the liver back into the bloodstream (regurgitation); or obstruction of the bile ducts. A healthy newborn may develop jaundice because the liver has not fully matured. This type of jaundice usually subsides within a few weeks when the liver begins to function properly. Neonatal jaundice is common, affecting some 50 to 60 percent of full-term infants and about 80 percent of infants born prematurely.
Jaundice is classified as unconjugated, hepatocellular, or cholestatic. The first type, unconjugated, or hemolytic, jaundice, appears when the amount of bilirubin produced from hemoglobin by the destruction of red blood cells or muscle tissue exceeds the normal capacity of the liver to transport it or when the ability of the liver to conjugate normal amounts of bilirubin into bilirubin diglucoronide is significantly reduced by inadequate intracellular transport or enzyme systems. The second type, hepatocellular jaundice, arises when liver cells are damaged so severely that their ability to transport bilirubin diglucoronide into the biliary system is reduced, allowing some of the yellow pigment to regurgitate into the bloodstream. The third type, cholestatic, or obstructive, jaundice, occurs when essentially normal liver cells are unable to transport bilirubin either through the hepatic-bile capillary membrane, because of damage in that area, or through the biliary tract, because of anatomical obstructions such as gallstones or cancer.
Some of the various diseases that can cause jaundice are hemolytic anemia, congestion in the circulatory system, pneumonia, congenital liver abnormalities, degeneration of the liver cells by poisons or infectious organisms, scarring of the liver tissue (cirrhosis), and obstructions or tumours in the liver, bile ducts, and the head of the pancreas.
In most cases, jaundice is an important symptom of some inherent bodily disturbance, but aside from the neonatal period the retention of bilirubin itself does not usually cause any greater damage than skin discoloration that lasts until the systemic problem is corrected. Cholestatic jaundice, especially if prolonged, can produce secondary disorders that may result in the failure of bile salts to reach the intestinal tract. Bleeding can occur in the intestines because of the absence of bile salts, for without them the fat-soluble vitamin K cannot be absorbed properly by the body. Without this vitamin, blood clotting is impaired, so that there is a greater tendency for bleeding to occur.